Skip to main content
. 2024 Sep 16;20(18):e1154–e1162. doi: 10.4244/EIJ-D-24-00037

Table 3. Multiple comparisons of femoropopliteal treatment location and clinical outcomes.

Adjusted hazard ratio (95% confidence interval) p-value
Target lesion revascularisation
PA vs SFA 0.82 (0.47-1.42) 0.667
SFA/PA vs SFA 1.48 (1.09-2.00) 0.008
SFA/PA vs PA 1.80 (1.00-3.27) 0.052
Major amputation
PA vs SFA 3.39 (0.61-18.70) 0.213
SFA/PA vs SFA 1.36 (0.34-5.42) 0.859
SFA/PA vs PA 0.40 (0.06-2.92) 0.525
Loss of patency
PA vs SFA 0.93 (0.70-1.25) 0.841
SFA/PA vs SFA 1.30 (1.08-1.56) 0.002
SFA/PA vs PA 1.39 (1.01-1.92) 0.043
Major adverse limb event
PA vs SFA 0.87 (0.51-1.48) 0.809
SFA/PA vs SFA 1.43 (1.06-1.92) 0.015
SFA/PA vs PA 1.64 (0.92-2.90) 0.106
All-cause death*
PA vs SFA 1.31 (0.60-2.84) 0.695
SFA/PA vs SFA 1.07 (0.62-1.85) 0.957
SFA/PA vs PA 0.82 (0.33-2.02) 0.858
*Analysis based on patient-level data. PA: popliteal artery; SFA: superficial femoral artery